Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Collins Stewart Analysts Downgrade Alcon, Inc. (NYSE: ACL) to “Hold”
Collins Stewart Analysts Downgrade Alcon, Inc. (NYSE: ACL) to “Hold”
Collins Stewart Analysts Downgrade Alcon, Inc. (NYSE: ACL) to “Hold”
Submitted by
admin
on December 19, 2010 - 11:30am
Source:
American Consumer News
News Tags:
Alcon
investors
Headline:
Collins Stewart Analysts Downgrade Alcon, Inc. (NYSE: ACL) to “Hold”
Do Not Allow Advertisers to Use My Personal information
